Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?

by Uri Amit, Yaacov R. Lawrence, Ilana Weiss, Zvi Symon
Published 2019-06-01

Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer

by Amir Onn, Teodor Gottfried, Amos Stemmer, Sarit Appel, Yaacov R. Lawrence, Damien Urban, Tamar Beller, Sameh Daher, Jair Bar
Published 2021-06-01

Dietary-Induced Ketogenesis: Adults Are Not Children

by Keren Porper, Leor Zach, Yael Shpatz, Bruria Ben-Zeev, Michal Tzadok, Elisheva Jan, Alisa Talianski, Colin E. Champ, Zvi Symon, Yair Anikster, Yaacov R. Lawrence
Published 2021-09-01

Nivolumab in Non-Small Cell Lung Cancer: Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

by Sameh Daher, Yaacov R. Lawrence, Elizabeth Dudnik, Ekaterina Hanovich, Damien Urban, Nir Peled, Rossie Navon, Raya Leibowitz, Ariel Hammerman, Erez Battat, Teodor Gottfried, Amir Onn, Jair Bar
Published 2021-07-01

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations.

by Michal Yalon, Liron Tuval-Kochen, David Castel, Itai Moshe, Inbal Mazal, Osher Cohen, Camila Avivi, Kineret Rosenblatt, Sarit Aviel-Ronen, Ginette Schiby, Joachim Yahalom, Ninette Amariglio, Raphael Pfeffer, Yaacov R Lawrence, Amos Toren, Gideon Rechavi, Shoshana Paglin
Published 2016-01-01